Details of the Drug Reposition

General Information of This Drug (ID: DMZ8WAQ)

Drug Name
Retroviral vector-transduced autologous T cells to express CD22-specific CARs   DMZ8WAQ
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Phase 1 [1]
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 1 [1]
Mantle cell lymphoma DISFREOV 2A85.5 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02721407) Anti-CD22 CAR-T Therapy for CD19-refractory or Resistant Lymphoma Patients